Why Do I Need a Muscle MRI for Welander Distal Myopathy?
At a Glance
While a genetic test confirms a Welander distal myopathy diagnosis, a muscle MRI is necessary to see exactly how the disease physically affects your body. The scan detects early fatty replacement in muscles and establishes a crucial baseline to track your condition's progression over time.
In this answer
3 sections
It is very common to wonder why you need an expensive and sometimes uncomfortable imaging test—like having to lie perfectly still inside an enclosed, noisy machine—when a simple genetic blood test has already confirmed you have Welander distal myopathy (WDM). While the genetic test identifies the specific DNA mutation causing your condition, it does not tell your care team how much that mutation is currently affecting your muscles. A muscle MRI is used to confirm the specific pattern of muscle damage, establish a baseline to track how your disease progresses over years or decades, and objectively measure the exact severity of muscle changes happening beneath the skin.
Seeing the Full Picture: Genes vs. Muscle Health
A genetic test confirms the “blueprint” of the disease, showing that you have a mutation (usually in the TIA1 gene) associated with Welander distal myopathy [1][2][3]. However, people with the exact same genetic mutation can experience very different levels of muscle weakness and disease progression.
An MRI (Magnetic Resonance Imaging) provides a detailed, inside look at the actual health of your muscles [4][5]. This allows your doctor to see how the genetic blueprint is actively behaving in your body [6][7]. Because an MRI is primarily looking at the structure of the muscle, this type of scan often does not require an IV or a contrast dye injection, which can make the test a bit easier to manage.
What Does the MRI Look For?
In Welander distal myopathy, the muscle tissue slowly breaks down over a period of many years and is replaced by fat, a process known as fatty replacement or fatty infiltration [8][1][9].
The MRI is highly sensitive to these changes and allows doctors to visualize specific patterns of muscle involvement:
- Identifying Specific Muscle Patterns: WDM typically affects the muscles furthest from the center of your body. The MRI can confirm fatty replacement in specific lower leg muscles, particularly the gastrocnemius and soleus (the main calf muscles), as well as the tibialis anterior (the muscle along the front of your shin) [10][11][9]. Crucially, the MRI is also used to evaluate the muscles in your hands and forearms, where weakness often begins in this specific condition [8][12].
- Catching Early Changes: An MRI can detect muscle damage and early fatty replacement before you even notice significant changes in your grip strength or walking ability [13][14][15].
Establishing a Baseline and Tracking Progression
Perhaps the most important role of a muscle MRI after a genetic diagnosis is establishing a baseline [6][7][16].
- Measuring Severity: The degree of fatty replacement seen on an MRI strongly correlates with the severity of the disease and your daily physical function [1][17][9]. This detailed assessment helps your doctor and physical therapist tailor a specific plan to support the muscles that are most at risk.
- Monitoring Change Over Time: By having a baseline scan, future MRIs can be compared to see exactly how quickly or slowly the fatty infiltration is progressing [9][1]. This provides objective data that is much more precise than simple physical strength tests [18][19].
Common questions in this guide
Why do I need an MRI if a genetic test already confirmed I have Welander distal myopathy?
What exactly does a muscle MRI look for in this condition?
Can an MRI detect Welander distal myopathy changes before I feel weakness?
Do I need a contrast dye injection for a muscle MRI?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Will this MRI scan evaluate both my upper extremities (hands/arms) and my lower extremities (legs)?
- 2.What specific muscle groups show the most fatty replacement on this MRI?
- 3.How does my current MRI compare to what is typically expected for someone at my stage of Welander distal myopathy?
- 4.How often should we repeat the muscle MRI to monitor the progression of the disease?
- 5.Are there any physical therapy interventions we should prioritize based on the vulnerable areas identified in the MRI?
- 6.Does this MRI require a contrast dye injection, or will it be a non-contrast scan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (19)
- 1
A Heterologous Cell Model for Studying the Role of T-Cell Intracellular Antigen 1 in Welander Distal Myopathy.
Carrascoso I, Sánchez-Jiménez C, Silion E, et al.
Molecular and cellular biology 2019; (39(1)) doi:10.1128/MCB.00299-18.
PMID: 30348840 - 2
Dynamics of T-Cell Intracellular Antigen 1-Dependent Stress Granules in Proteostasis and Welander Distal Myopathy under Oxidative Stress.
Fernández-Gómez A, Velasco BR, Izquierdo JM
Cells 2022; (11(5)) doi:10.3390/cells11050884.
PMID: 35269506 - 3
Welander Distal Myopathy-Associated TIA1 E384K Mutation Disrupts Stress Granule Dynamics Under Distinct Stress Conditions.
Ramos-Velasco B, Alcalde J, Izquierdo JM
Biology 2025; (14(9)) doi:10.3390/biology14091288.
PMID: 41007432 - 4
Myopathology in times of modern imaging.
Jungbluth H
Neuropathology and applied neurobiology 2017; (43(1)):24-43 doi:10.1111/nan.12385.
PMID: 28111795 - 5
Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA-Related Muscular Dystrophy.
Lin HT, Liu X, Zhang W, et al.
Chinese medical journal 2018; (131(12)):1472-1479 doi:10.4103/0366-6999.233957.
PMID: 29893365 - 6
The value of qualitative muscle MRI in the diagnostic procedures of myopathies: a biopsy-controlled study in 191 patients.
Lehmann Urban D, Mohamed M, Ludolph AC, et al.
Therapeutic advances in neurological disorders 2021; (14()):1756286420985256 doi:10.1177/1756286420985256.
PMID: 33737953 - 7
Imaging alterations in skeletal muscle channelopathies: a study in 15 patients.
Maggi L, Brugnoni R, Canioni E, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2015; (34(2-3)):109-15.
PMID: 27199537 - 8
Whole Exome Sequencing Identifies Atypical Welander Distal Myopathy in Patient.
Gass J, Blackburn P, Jackson J, et al.
Journal of clinical neuromuscular disease 2017; (18(3)):152-156 doi:10.1097/CND.0000000000000164.
PMID: 28221306 - 9
Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients.
Bermejo-Guerrero L, de Fuenmayor Fernández-de la Hoz CP, González-Quereda L, et al.
Neuromuscular disorders : NMD 2023; (33(12)):983-987 doi:10.1016/j.nmd.2023.10.016.
PMID: 38016875 - 10
Autosomal dominant distal myopathy due to p.Ser85Cys mutation in the MATR3 gene: Novel case series and literature review.
Chitimus DM, Venturelli N, Lefeuvre C, et al.
Revue neurologique 2025; (181(7)):608-614 doi:10.1016/j.neurol.2025.04.011.
PMID: 40447473 - 11
Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes.
Kumutpongpanich T, Ogasawara M, Ozaki A, et al.
JAMA neurology 2021; (78(7)):853-863 doi:10.1001/jamaneurol.2021.1509.
PMID: 34047774 - 12
Panorama of the distal myopathies.
Savarese M, Sarparanta J, Vihola A, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):245-265 doi:10.36185/2532-1900-028.
PMID: 33458580 - 13
Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity.
Klickovic U, Zampedri L, Sinclair CDJ, et al.
Neurology 2019; (93(9)):e895-e907 doi:10.1212/WNL.0000000000008009.
PMID: 31391248 - 14
Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
Mul K, Vincenten SCC, Voermans NC, et al.
Neurology 2017; (89(20)):2057-2065 doi:10.1212/WNL.0000000000004647.
PMID: 29030457 - 15
Muscle-MRI and Functional Levels for the Evaluation of Upper Limbs in Duchenne Muscular Dystrophy: A Critical Review of the Literature.
Cristiano L, Brogna C, Tasca G, et al.
Medicina (Kaunas, Lithuania) 2022; (58(3)) doi:10.3390/medicina58030440.
PMID: 35334617 - 16
Juvenile Dermatomyositis: Key Roles of Muscle Magnetic Resonance Imaging and Early Aggressive Treatment.
Corral-Magaña O, Bauzá-Alonso AF, Escudero-Góngora MM, et al.
Actas dermo-sifiliograficas 2018; (109(6)):e42-e46 doi:10.1016/j.ad.2017.07.003.
PMID: 28911766 - 17
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
Alonso-Jimenez A, Kroon RHMJM, Alejaldre-Monforte A, et al.
Journal of neurology, neurosurgery, and psychiatry 2019; (90(5)):576-585 doi:10.1136/jnnp-2018-319578.
PMID: 30530568 - 18
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study.
Fionda L, Leonardi L, Tufano L, et al.
Journal of neurology 2024; (271(9)):5864-5874 doi:10.1007/s00415-024-12544-5.
PMID: 38972019 - 19
Semi-automated volumetry of MRI serves as a biomarker in neuromuscular patients.
Müller M, Dohrn MF, Romanzetti S, et al.
Muscle & nerve 2020; (61(5)):600-607 doi:10.1002/mus.26827.
PMID: 32022288
This page explains the role of muscle MRIs in Welander distal myopathy for educational purposes only. Always consult your neurologist or care team regarding your specific imaging and diagnostic needs.
Get notified when new evidence is published on Distal myopathy, Welander type.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.